Mode
Text Size
Log in / Sign up

Post-diagnosis physical activity of 7.5 MET-hr/week associated with lower all-cause mortality in prostate cancerHigher physical activity linked to lower death rates in prostate cancer

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that higher levels of post-diagnosis physical activity are associated with lower mortality in men with prostate cancer.

This meta-analysis evaluated the relationship between physical activity and mortality outcomes in a large cohort of men diagnosed with prostate cancer. The study pooled data from 10 different studies, encompassing a total population of more than 50,144 participants. The primary focus was on post-diagnosis physical activity measured in MET-hr/week to determine its association with survival rates.

The researchers compared patients who engaged in higher levels of physical activity (defined as greater than or equal to 7.5 MET-hr/week) against those with lower levels of activity (less than 7.5 MET-hr/week). The analysis specifically looked at all-cause mortality and prostate cancer-specific mortality as the primary endpoints for evaluating the impact of exercise on patient outcomes.

Regarding the primary outcome, higher levels of post-diagnosis physical activity (greater than or equal to 7.5 MET-hr/week) were associated with lower all-cause mortality. The reported effect size was an HR of 0.69 (95% CI: 0.62-0.77). For the secondary outcome of prostate cancer-specific mortality, there was a significant inverse association with higher physical activity levels, yielding an HR of 0.77 (95% CI: 0.66-0.89).

Additionally, the meta-analysis examined specific types of exercise. Moderate-to-vigorous physical activity was inversely associated with mortality, showing a hazard ratio of 0.62 (95% CI: 0.51-0.74). These results indicate that both general high-volume activity and specifically moderate-to-vigorous intensity are linked to improved survival outcomes in this population.

Safety and tolerability data were not reported for the study, including specific rates of adverse events or treatment discontinuations. While the association between physical activity and mortality is statistically significant across the meta-analysis, it is important to note that these findings do not establish a causal relationship due to the observational nature of the underlying data. The results provide evidence that physical activity may complement standard cancer care for patients with prostate cancer. However, clinical implementation must consider that one study in the meta-analysis did not report the specific number of prostate cancer cases included. The findings should be interpreted as associations rather than definitive proof of causality.

Several questions remain regarding the optimal intensity and duration of exercise programs specifically tailored for prostate cancer patients. Furthermore, while the association with mortality is clear, the impact on quality of life or specific symptom management was not detailed in this analysis. Clinicians may consider these findings when discussing supportive care options with patients to encourage physical activity as a complementary component of their management plan.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in the management of prostate cancer by highlighting the role of lifestyle factors, specifically physical activity, in improving survival outcomes. While previous coverage has focused on diagnostic tools such as MRI-based artificial intelligence models for predicting biochemical recurrence and PSMA-targeted radioguided surgery for nodal staging, this meta-analysis provides evidence that post-diagnosis physical activity is associated with lower all-cause mortality (HR 0.69) and prostate cancer-specific mortality (HR 0.77).

Living with a prostate cancer diagnosis brings many questions about what can be done to improve long-term health. While medical treatments are the primary focus, researchers are looking closely at how lifestyle choices, like staying physically active, might play a role in a patient's journey. This research looks specifically at whether moving more after a diagnosis helps men live longer.

The researchers conducted a meta-analysis, which is a way of combining and analyzing data from many different studies to find broader patterns. They looked at information from over 50,144 men living with prostate cancer across ten different studies. The goal was to see if there was a link between how much physical activity these men did after their diagnosis and their risk of death.

The results showed that men who engaged in higher levels of physical activity had lower rates of all-cause mortality. Specifically, those who reached a certain threshold of activity were less likely to die from any cause compared to those with lower activity levels. The data also suggested that more active men had a lower risk of dying specifically from prostate cancer. Furthermore, the study found that moderate to vigorous physical activity—meaning exercise that gets your heart rate up—was linked to even lower mortality rates.

It is important to keep these findings in a realistic perspective. While the numbers show a strong link between movement and survival, this type of study shows an association rather than a direct cause. This means that while being active is linked to better outcomes, we cannot say for certain that exercise alone causes those improvements or how much of the benefit comes from it. Additionally, one of the studies included in the analysis did not report the exact number of prostate cancer cases, which adds a small layer of uncertainty to the total data.

For patients today, this means that staying active is something worth discussing with a doctor as part of a complete care plan. It suggests that movement can be a helpful addition to standard medical treatments for prostate cancer. Because every patient's health and fitness level are different, it is best to talk to a healthcare provider about what kind of activity is safe and appropriate for your specific situation.

What this means for you:
Men with prostate cancer who stay active after diagnosis show lower rates of death from all causes.

Study Details

Study typeMeta analysis
Sample sizen = 50,144
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: Physical activity after cancer diagnosis may reduce mortality. However, systematic evidence for this association for men living with prostate cancer remains limited. METHODS: We searched PubMed, Embase, and CINAHL data bases from start to June 2025. Random-effects meta-analyses estimated summary hazard ratios (HRs) and 95% confidence intervals (CI) for all-cause mortality and prostate-cancer-specific mortality to assess the association between post-diagnosis physical activity, measured in metabolic equivalents of task-hours per week (MET-hr/week), and mortality among prostate cancer survivors. RESULTS: We included ten studies with more than 50,144 participants (one study did not report the number of prostate cancer cases included in the meta-analysis) and 28,044 deaths. Higher levels of post-diagnosis physical activity (≥ 7.5 MET-hr/week) were associated with lower all-cause mortality (HR = 0.69; 95% CI: 0.62-0.77), compared to lower levels (< 7.5 MET-hr/week). Meta-analysis of five studies showed an inverse association between post-diagnosis physical activity and prostate cancer-specific mortality (HR = 0.77; 95% CI: 0.66-0.89). Meta-analysis of four studies showed that moderate-to-vigorous physical activity was inversely associated with mortality (HR = 0.62; 95% CI: 0.51-0.74). CONCLUSION: Higher post-diagnosis physical activity, including activity at higher intensities, was associated with lower all-cause and prostate cancer-specific mortality among men living with prostate cancer. Our findings suggest that physical activity may complement cancer care for prostate cancer patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.